Sustainability Now cover image

Diet ESG

Sustainability Now

00:00

The Risks of Off Label Marketing for Weight Loss Drugs

Companies have to maintain a stance that they cannot do off label marketing. They will not allow the drug to be prescribed for anything other than what it has been indicated for but Vigovi is already indicated for weight loss. The undiscovered side effects there have already been reports of side effects hitting people that are using ozempic for weight loss such as diarrhea vomiting constipation dizziness nausea. As these new higher dose drugs are introduced new problems could crop up animal studies have shown a higher incidence of thyroid cancer and also semi-glutide is associated with rare pancreatitis. i want to know from the media how we score novo nordisc overall on esg factors if it is

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app